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Abstract
Background: The aim of the study was to assess the correlation between the tuberculin skin test (TST) and in vitro
interferon-gamma released assays (IGRAs) with risk factors for the spread of infection in smear positive pulmonary
tuberculosis (TB) contacts.
Methods: We recruited prospective contacts with smear positive pulmonary TB cases. We looked at human
immunodeficiency virus (HIV) infection and other conditions of immunosuppression, presence of BCG vaccination
and the degree of exposure to the index case. Patients underwent the TST, chest radiography, sputum analysis
when necessary, and IGRA assays (QFN-G-IT and T-SPOT.TB). Presence of cough, diagnostic delay (days between first
symptoms and TB diagnostic), contact conditions: room size (square meters) and index of overcrowding (square
meters per person) were investigated in the index case.
Results: 156 contacts (119 adults, 37 children) of 66 TB patients were enrolled, 2.4 (1-14) contacts per TB case. The
positivity of the TST did not correlate with the risk factors studied: presence of cough (p = 0.929); delayed diagnosis
(p = 0.244); room size (p = 0.462); overcrowding (p = 0.800). Both QFN-G-IT and T-SPOT.TB, showed significant association
with cough (p = 0.001, and p = 0.007) and room size (p = 0.020, and p = 0.023), respectively.
Conclusions: Both IGRA associated better than TST with certain host-related risk factors involved in the transmission of
disease, such as the presence of cough.
Keywords: Tuberculosis infection, Tuberculin skin test, Interferon gamma release assays, IGRA, Overcrowding, Diagnostic
delay, Cough
Background
The World Health Organization estimates approximately
8.6 million new cases of tuberculosis (TB) annually [1].
Studies published in the 80s showed that 5-10% of
recently infected contacts develop active disease within
the subsequent 2-5 years after exposure to an infectious
source; while another 5-10% percent develop TB sometime
during the rest of their lives [2]. In Barcelona, a low TB
burden city (incidence: 24.9/100,000 in 2011), a study
showed that 25.5% of new TB cases were due to recent
transmission [3].
TB prevention relies on the targeted identification and
preventive treatment of individuals who carry an increased
risk of developing TB [4]. Identification of individuals from
these groups, showing the highest risk of developing TB is
performed by the evaluation of the presence of an adaptive
immunity against Mycobacterium tuberculosis, in the ab-
sence of active disease. For many decades the tuberculin
skin test (TST) has been the immunodiagnostic method of
* Correspondence: msouza@vhebron.net
1Unitat de Tuberculosi de Drassanes, Hospital Universitari Vall d’Hebron,
Barcelona, Spain
2IDIAP Jordi Gol Research Foundation, Barcelona, Spain
Full list of author information is available at the end of the article
© 2014 de Souza-Galvão et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public
Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this
article, unless otherwise stated.
de Souza-Galvão et al. BMC Infectious Diseases 2014, 14:258
http://www.biomedcentral.com/1471-2334/14/258
choice for this risk analysis. In the last years, interferon–γ
(IFN-γ) release assays (IGRAs), the Quantiferon-TB
Gold in Tube (QFN-G-IT) (QIAGEN, Düsseldorf,
Germany), and the T-SPOT.TB (Oxford Immunotec
Limited, Abingdon, UK), have been introduced into
clinical practice as laboratory methods for the immune-
diagnosis of latent TB infection (LTBI) [5].
The spread of TB in confined spaces is strongly influ-
enced by the number of infected droplet nuclei present
in the air, the viability of the M. tuberculosis bacilli and
the duration of exposure [6]. Living in a crowded house-
hold increases the risk of TB infection [7]. The presence
of cough decreases the delay in TB diagnostic, improv-
ing suspicion, also increasing the spread of the disease
[8]. While several studies have compared the frequency
of positive TST and IGRA results in relation to the
exposure time to case index [9,10], no study comparing
the performance of the TST and IGRAs was targeted
directly in living conditions and on overcrowding, as risk
factors for the development of LTBI in contacts.
The aim of this study was to assess the association
between the positivity of TST and IGRAs with some risk
factors for the spread of the disease as: presence of a
cough and diagnostic delay in the index case; and the
size of the room and the overcrowding in the environ-
ment where the contact took place. Furthermore, we
compared the performance of the 3 tests, the agreement




We prospectively recruited people who came to the TB
Unit in Drassanes (Barcelona, Spain) in our routine con-
tact investigation tasks. The Ethics Committee of the
“IDIAP Jordi Gol Research Foundation” provided ethics
approval for this study. Patients and parents of children
were asked to sign a consent form. Detailed question-
naires were completed with data about prior contact or
any prior TST result; data about HIV infection or other
causes of immunosuppression were collected and we
looked for the presence of BCG scars. We tested using
TST and whenever possible, also with QFN-GIT and
with T-SPOT.TB. We drew blood only from untreated
patients or from patients receiving LTBI treatment for
less than 30 days, in order to avoid the effects of the
therapy skewing IGRA results [11]. Chest x-Ray and
sputum analysis were also done if necessary.
Contacts were eligible if they were exposed to a
pulmonary TB sputum smear positive patient index, and
excluded if they had active TB, were diagnosed with HIV
infection, were pregnant, or if the result of the culture of
the patient index was not confirmed to be M. tubercu-
losis. Contacts of sputum smear positive patients were
from two different origins: familial (relatives or friends
referred to the Unit for TB screening) and community
(colleagues or students referred to the Unit for screening
with chest x-Ray due to a positive TST). They were also
classified according to degree of exposure to the case
index in 2 groups: 6 or more hours daily and less than
6 hours daily. Clinicians were blind to IGRA results and
microbiologists did not know the clinical history of the
patients.
Clinical and environmental risk factors for TB infection
In the index case we checked for the presence or ab-
sence of a cough and considered the days of diagnostic
delay, defined as days between the first symptoms and
TB diagnostic. As far as the environmental contact con-
ditions, we looked for data on the room size (in square
meters) and we used the Floor Area per Person Index.
The room size was classified according to the Statistical
Institute of Catalonia, slightly adapted to the characteris-
tics of the neighbourhood of our study population. This
indicator of Sustainable Development was used by the
United Nations, to measure the adequacy of living
space, not taking into account cultural differences, as an
indicator of overcrowding. We considered overcrowding
when the index was less than 15 square meters per per-
son [12]. The data about the index case were obtained
by direct interview when the patient was diagnosed in
our institution or collected from the database of the TB
Programs of Barcelona and Catalonia.
Tuberculin skin testing
TST was performed by the Mantoux method using two
tuberculin units of PPD RT23 (Statens Serum Institut,
Copenhagen, Denmark) and read within 48-72 h, using
the ball-point pen and ruler method by trained nurses and
doctors. All TST ≥ 5 mm were classified as positive result
regardless of the BCG defined by the Spanish Pneumology
and Thoracic Surgery Society (SEPAR) guidelines [13,14].
QFN-gold in tube
One ml of blood was drawn per each of the 3 tubes with
antigens ready for incubation: (Nil, TB antigens and
mitogen). Samples were incubated with stimulatory anti-
gens for 16 h-24 h and the test was performed according
to the manufacturer’s instructions. The cut-off value for
a positive test was IFN-γ of at least 0.35 IU/mL in the
sample after stimulation with the specific antigens, re-
gardless of the result of the mitogen control. The result
of the test was considered indeterminate if the antigen-
stimulated sample was negative and if the value of the
positive control was less than 0.5 IU/mL after subtrac-
tion of the value of the nil control, and/or if the nil
control was higher than 8.0 IU/ml.
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T-SPOT.TB
The test was performed following manufacturer’s recom-
mendations. 8 ml of blood were drawn from each
subject by venipuncture for the isolation of peripheral
blood mononuclear cells (PBMCs) in CPT tube (Beckton
Dickinson Diagnostics, Franklin Lakes, NJ). The isolated
PBMCs were washed twice by centrifugation with RPMI
medium (Invitrogen, Auckland, N.Z.), and later resus-
pended in AIM-V medium (Invitrogen, Auckland, N.Z.).
Finally, viable cells were counted with an inverted micro-
scope using the tripan blue method.
After that, the PBMCs were stimulated in each well by
medium alone (as nil control), phytohaemagglutinin (as
positive control), different peptide panels encompassing
the antigens ESAT-6 and CFP-10. Spots were scored
using an automated AID ELISPOT plate reader (AID
Systems, Strasberg, Germany) and also by naked eye.
Test wells were scored as positive if they contained at
least six spot-forming cells more than the nil control
well, and if this number was at least twice the number of
the nil control well. The result of the test was considered
undetermined if the antigen-stimulated sample was nega-
tive and if the value of the positive control was less than 20
spots, and/or if the number of SFC in the negative control
was greater than 10. All blood samples for both tests were
processed within 4 h of phlebotomy in the Microbiology
Department of the Hospital Universitari Germans Trias i
Pujol in Badalona (Spain).
Statistical analysis
The qualitative variables description is based on the
calculation of the number and its percentage, and for
quantitative variables, based on calculation of the mean
and the standard deviation (SD). The chi-squared test and
two-tailed Fisher’s exact test were used to compare quali-
tative variables. Non-parametric tests (Mann–Whitney,
Kolmogorov-Smirnov, Kruskal-Wallis) were used to com-
pare quantitative variables according to the categories of
the group of variable. Cohen’s kappa coefficient (k) was
used to analyse the concordance and its p value. All
analyses were made with SPSS statistical software for
Windows (SPSS version 15.0; SPSS, Chigago, IL).
Results
Demography
Table 1 summarizes the demographic and clinical details.
230 contact patients with smear positive TB were recruited
for the study. 11 patients were excluded by diagnosis of
active TB; 5 by absence of growth of M. tuberculosis in the
culture sputum of the index case and 34 because the blood
samples were collected more than 30 days after they had
started treatment of TB infection. 24 contacts did not have
all three testing techniques applied. In the end, a total of
156 contacts (119 adults and 37 children) from 66 cases of
pulmonary TB sputum smear positive were enrolled
(Figure 1). The average number of close contacts per source
case was 2.4 and varied from 1 to 14 individuals.
Agreement between tests
Overall agreement of TST and both IGRAs was mostly
slight (Table 2). Nevertheless, in BCG-unvaccinated chil-
dren reached the best agreement. The overall agreement
between both IGRAs was substantial; with no differ-
ences in the agreement in BCG-vaccinated and non-
BCG-vaccinated taking into account children and adults
together.
Positive test results for all techniques
The results of TST and IGRAs are summarised separately
into adults and children according with the origin of the
contact (familial or community contact) in Figure 2, and
also according to the presence or absence of BCG vaccine
and the degree of exposure (Tables 3 and 4).
Table 1 Characteristics of the study population (n = 156)
Characteristics Adults n = 119 Children n = 37
Mean age (SD) 29.3 (10.5) 9.2 (2.4)
Gender
Female 67 (56.3) 21 (56.8)
Male 52 (43.7) 16 (43.2)
BCG-vaccinated
Yes 69 (58) 25 (67.6)
No 50 (42) 12 (32.4)
Place of birth
Spain 60 (50.4) 12 (32.4)
Outside Spain 59 (49.6) 25 (67.6)
America 42 (71.2) 19 (76)
Eastern Europe Mediterranean 7 (11.9) 1 (4)
Europe 6 (5) 5 (13.5)
South Asia 1 (1.7) 0 (0)
Western Pacific 3 (5.1) 0 (0)
Type of contact
Familial 45 (37.8) 25 (67.6)
Community 74 (62.1) 12 (32.4)
Degree of exposure
≥ 6 hours daily 46 (38.6) 16 (43.2)
< 6 hours daily 73 (61.4) 21 (56.8)
Cough in index case
Yes 37 (52.1) 23 (92)
No 34 (47.9) 2 (8)
Data are presented as n (%) or means ± SD. BCG: Bacille Calmette-Guérin.
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BCG-unvaccinated
The results of the TST showed 46 (92%) positive adults
and 11 (91%) positive children (Table 3). The QFN-G-IT
was positive in 27 (54%) adults and 9 (75%) children,
while the T-SPOT.TB was positive in 33 (66%) and inde-
terminate in 2 (4%) adults; and positive in 10 (83.3%)
children with no indeterminate results.
BCG-vaccinated
Percentages of positive results in TST were similar to
those of non-vaccinated individuals (92.8% and 92% in
adults and children, respectively) (Table 4). In contrast,
IGRAs detected less positive results compared to the
unvaccinated groups, except for T-SPOT.TB in children.
Positive test results according to degree of exposure
BCG-unvaccinated contacts
TST positive results did not correlate with the degree
of exposure in adults, showing identical percentage of
positive results independently of the degree exposure
(Table 3). In contrast, although IGRAs showed a higher
amount of positive results with the increase of hours of
Figure 1 Patients included and causes for exclusion from the study (TB: tuberculosis. LTBI: latent tuberculosis infection).
Table 2 Agreement between tests and Κ coefficients
Patient
characteristics
TST versus T-SPOT-TB TST versus QFN-IT T.SPOT-TB versus QFN-IT
Agreement (%) Kappa Agreement (%) Kappa Agreement (%) Kappa
Total
All 62.6 0.172 50.91 0.121 82.82 0.659
BCG 51.58 0.119 42 0.078 83.84 0.664
No BCG 79.37 0.310 64.62 0.224 81.25 0.604
Adults
All 58.97 0.148 45.6 0.100 81.45 0.629
BCG 47.83 0.101 34.72 0.056 80.82 0.580
No BCG 75 0.256 60.38 0.195 82.35 0.637
Children
All 75 0.288 69.23 0.235 86.84 0.721
BCG 64 0.199 62.96 0.182 92 0.838
No BCG 93.33 0.634 83.33 0.429 76.92 0.418
BCG: Bacille Calmette-Guérin. TST: tuberculin skin test. QFN-G-IT: Quantiferon-TB Gold in tube.
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exposure to the index case, the differences did not
reached statistical significance.
Taking into account the same degree of exposure,
significant differences were found between the positive
results using the 3 techniques. TST compared with
QFN-G-IT and T-SPOT.TB showed more significant
positive results in both degrees of exposure: more than
6 hours (p = 0.007 and p = 0.022, respectively) and less
than 6 hours (p < 0.001, respectively) in adults. The
low number of BCG-unvaccinated children included,
did not allow us to establish if there was a statistical
association in this group.
BCG-vaccinated contacts
TST did not show a significant difference in the number of
positive results according to the degree of exposure, neither
in adults nor in children (Table 4). In opposite, although
IGRAs showed a higher amount of positive results with the
increase of hours of exposure to the index case, the differ-
ences did not reached statistical significance.
Taking into account the same degree of exposure,
significant differences were found between the positive
results using the 3 techniques. TST compared with
QFN-G-IT and T-SPOT.TB showed more positive
results in both degrees of exposure: more than 6 hours
(p < 0.001, respectively) and less than 6 hours (p <
0.001, respectively) in adults and the same in children
(p = 0.018 and 0.016, respectively).
Quantitative evaluation of T-cell response according to
the degree of exposure
We studied T-cell quantitative enumeration after stimu-
lation with ESAT-6, CFP-10 and also the sum of both
antigens together (ESAT6/CFP10) with T-SPOT.TB; and
the amount of IFN-γ release in QFT-G-IT, in the contacts
included, according to the different degrees of exposure to
the index case. In adults, we found a higher amount of
responding T cells after stimulation with CFP-10 (p =
0.029), ESAT6/CFP10 (p = 0.042) and in the amount of
IFN-γ released (p = 0.015) (Figure 3) in contacts with >6 h
of exposure, in comparison to the contacts with <6 h of
exposure. In children, this analysis was not possible, given
the low number of children included.
Positive results according to clinical and environmental
risk factors
We studied 4 risk factors likely associated with TB infec-
tion: “presence of cough”, “days of diagnostic delay”,
“size of the household contact” and “overcrowding”, and
their relation with the positivity of the TST, QFN-GIT
and T-SPOT.TB. In the paediatric population, the posi-
tivity of the techniques was not correlated with any of
the risk factors studied. Data concerning the adult popu-
lation is presented in Table 5. For the TST, the positivity
of the test was not correlated with any of the risk factors
studied. On the other hand, we found that the positivity
of both IGRAs tests were associated with presence of
Figure 2 Number of positive results obtained by TST and both
IGRA tests (T-SPOT.TB and QFN-G-IT) in adults and children,
including information in each case of the origin of the contact:
familial (■) or from the community (□).
Table 3 Results of interferon-γ release assays and tuberculin skin test in adults and children BCG-unvaccinated
Adults Children
Technique Degree of exposure Degree of exposure
> 6 h daily < 6 h daily Total p > 6 h daily < 6 h daily Total p
TST Positive 18 (94.7) 28 (90.3) 46 (92) 0.820 2 (100) 9 (90) 11 (91) 0.999
Negative 1 (5.3) 3 (9.7) 4 (8) 0 (0) 1 (10) 1 (9)
QFN-G-IT Positive 13 (68.4) 14 (45.2) 27 (54) 0.173 2 (100) 7 (70) 9 (75) 0.999
Negative 6 (31.6) 17 (54.8) 23 (46) 0 (0) 3 (30) 3 (25)
Indeterminate 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
T.SPOT-TB Positive 15 (78.9) 18 (58) 33 (66) 0.223 2 (100) 8 (80) 10 (83.3) 0.999
Negative 4 (21.1) 11 (35.5) 15 (30) 0 (0) 2 (20) 2 (16.7)
Indeterminate 0 (0) 2 (6.5) 2 (4) 0 (0) 0 (0) 0 (0)
Data are presented as n (%). BCG: Bacille Calmette-Guérin. TST: tuberculin skin test. QFN-G-IT: Quantiferon-TB Gold in tube.
Two-tailed statistical test was used to compare the qualitative results of TST, QFN-G-IT and T-SPOT.TB, respectively, between the two degree of exposure
categories in adults and children.
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Table 4 Results of interferon-γ release assays and tuberculin skin test in adults and children BCG-vaccinated
Adults Children
Technique Degree of exposure Degree of exposure
> 6 h daily < 6 h daily Total p > 6 h daily < 6 h daily Total p
TST Positive 27 (100) 37 (88.1) 64 (92.7) 0.998 13 (92.9) 10 (90.9) 23 (92) 0.859
Negative 0 (0) 5 (11.9) 5 (7.3) 1 (7.1) 1 (9.1) 2 (8)
QFN-G-IT Positive 9 (33.3) 10 (23.8) 19 (27.5) 0.622 9 (64.3) 5 (45.5) 14 (56) 0.350
Negative 17 (63) 32 (76.2) 49 (71) 5 (35.7) 6 (54.5) 11 (44)
Indeterminate 1 (3.7) 0 (0) 1 (1.5) 0 (0) 0 (0) 0 (0)
T.SPOT-TB Positive 14 (51.8) 14 (33.3) 28 (40.6) 0.175 9 (64.3) 5 (45.5) 14 (56) 0.350
Negative 13 (48.2) 28 (66.7) 41 (59.4) 5 (35.7) 6 (54.5) 11 (44)
Indeterminate 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Data are presented as n (%). BCG: Bacille Calmette-Guérin. TST: tuberculin skin test. QFN-G-IT: Quantiferon-TB Gold in tube.
Two-tailed statistical test was used to compare the qualitative results of TST, QFN-G-IT and T-SPOT.TB, respectively, between the two degree of exposure
categories in adults and children.
Figure 3 Number of responder T cells to ESAT-6 (A), CFP-10 (B), ESAT6/CFP10 (C), and IFN-γ released after specific antigens stimulation
(D) in more and less than 6 hours of exposition to the index case.
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cough and with the household size, but in this case,
inversely to what was expected: we found more positive
results, the more square meters the room contained.
In T-SPOT.TB results, there was a trend towards an
association with diagnostic delay. Overcrowding was not
associated with the positivity of any of the tests. The
unexpected result of the household size was attributed
to the association found between household size and the
degree of exposure: contacts living in larger homes had
been exposed longer to the index case. Logistic regression
analysis was not performed since the number of cases
having all the variables to be analyzed, was insufficient.
Discussion
To our knowledge, this is the first study that has investi-
gated the role of the environment and of host-related
risk factors for TB infection using TST and IGRAs. We
compared the risk of positivity of TST, QFN-GIT and
T-SPOT.TB and related them to risk factors of the index
case, such as presence of a cough and delayed diagnosis,
and also included environmental characteristics, such as
household size and overcrowding.
The use of IGRAs has increased specificity in the diag-
nosis of LTBI, and has proven greater cost efficiency, es-
pecially in the use of preventive therapy [15,16]. Several
studies have compared the performance of the IGRAs
against the performance of TST, taking into account the
time of exposure from a contagious source and the
infectiousness of the source [17-19].
In our experience, the agreement between IGRA tests
and TST was slight (especially in BCG-vaccinated), while
the agreement between both IGRA tests was substantial
and similar in BCG-unvaccinated and BCG-vaccinated
contacts. The results suggest, as in previous studies, that
IGRA tests are less affected by BCG vaccination than
TST [9,19].
In general there is a recognized low capacity of IGRAs
to detect LTBI in children, especially in young children.
In our study, it is important to point out that the per-
centage of TST-positive results (in children and adults)
was high because most were referred to the Unit for
study by positive TST after a contact. This may explain
the high percentage of positive results obtained in
children included in the study.
A possible explanation for the lack of relation ob-
served between the positivity of the tests and the degree
of exposure, could be the fact that we enrolled only con-
tacts of patients showing smear-positive TB. This may
have biased the sample of patients towards being more
advanced in the disease, thus underestimating the effects
of other variables. This inclusion criteria, was used in
order to increase the likelihood of positive TST, attempt-
ing to get the majority of cases due to recent contact
with the case study and not simply due to a previous
infection.




n (%) n (%) n (%)
Positive Negative p Positive Negative p Positive Negative p
Cough
Yes 34 (94.4) 2 (5.6) 0.929 22 (61.1) 14 (38.9) 0.001 25 (69.5) 11 (30.5) 0.007
Not 31 (93.9) 2 (6.1) 7 (21.2) 26 (78.8) 12 (36.4) 21 (63.6)
Diagnostic delay
<30 35 (97.2) 1 (2.8) 0.244 11 (30.5) 25 (69.5) 0.565 14 (38.9) 22 (61.1) 0.077
30-59 13 (76.5) 4 (23.5) 7 (41.2) 10 (58.8) 7 (41.2) 10 (58.8)
60-89 17 (85) 3 (15) 7 (35) 13 (65) 9 (45) 11 (55)
>89 25 (100) 0 (0) 12 (48) 13 (52) 18 (72) 7 (28)
Room’s size (m2)
≤50 2 (66.7) 1 (33.3) 0.462 1 (33.3) 2 (66.7) 0.020 2 (66.7) 1 (33.3) 0.023
51-79 15 (78.9) 4 (21.1) 4 (21.1) 15 (78.9) 6 (31.6) 13 (68.4)
≥80 19 (90.5) 2 (9.5) 14 (66.7) 7 (33.3) 16 (76.2) 5 (23.8)
Overcrowding
≤15 7 (87.5) 1 (12.5) 0.800 2 (28.6) 5 (71.4) 0.480 5 (62.5) 3 (37.5) 0.820
>15 26 (83.9) 5 (16.1) 16 (51.6) 15 (48.4) 18 (58.1) 13 (41.9)
TST: tuberculin skin test. QFN-G-IT: Quantiferon-TB Gold in tube.
Diagnostic delay: days between first symptoms and TB diagnostic. Overcrowding: floor area index per person (square meters per person).
Two-tailed statistical test was used to compare the qualitative results of TST, QFN-G-IT and T-SPOT.TB, respectively, between the different categories of the risk
factors studied.
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The number of responder T cells and the amount of
IFN-γ released could be a better indicator of infectious-
ness, than the qualitative positivity of an IGRA test, as
seen in other studies [20]. We even found correlation be-
tween the degree of exposure and the number of responder
T cells to CFP-10 and ESAT6/CFP10 by TSPOT.TB and
the amount of IFN-γ released in adults.
Most transmissions occur between the onset of cough-
ing and the starting of the treatment [21]. It is known
that the delay in diagnosis determines disease progres-
sion, increasing affected lung areas with the occurrence
of cavitated lesions, extending the probability of infect-
ing a new contact. In this study, neither TST nor IGRAs
demonstrated to be related to diagnostic delay.
Sputum smear positivity should be considered a risk
factor for infectiousness but there are both epidemio-
logic [22] and experimental studies [23] that have shown
considerable variability of infectiousness among sputum
smear-positive patients. Some studies suggested that the
presence of a cough could generate potentially infectious
aerosols that may increase the risk of disease transmis-
sion, regardless of the sputum smear status in the index
case [24,25]. Our results showed that the positivity of
both IGRA tests was associated with the presence of a
cough. The potential of infectiousness is related to the
patient’s ability to aerosolise bacilli and to the number of
bacilli that are aerosolised. In a study in Uganda, contacts
of TB patients who produced high aerosols were more
likely to have a new infection, as opposed to those who pro-
duced low aerosols, and the aerosol negative cases [26].
Since we enrolled only contacts with smear positive
TB patients, it was not possible to examine the effect of
smear negative and the positivity of tests when the index
case had a cough. Guwatudde et al. [27], using TST,
studied 1,206 household contacts with smear positive
pulmonary. All the TB index cases had a cough for more
than 3 weeks and 86% had an advanced disease. Among
the host-related risk factors (including overcrowding), they
found that only cavitary disease and a prolonged contact
with an index case were independently associated with TB
in the contact, and the “muzigo” type of housing; a building
with multiple rooms that often share air space.
These findings are similar to those of our study, where
we did not find a correlation between the overcrowding
with the positivity of the tests. The number of patients
living in crowded conditions was low in our sample,
probably due to the characteristics of the individuals:
almost 50% natives and 50% immigrants from Latin Ameri-
can countries, a kind of population with enough resources
to live in family groups, in relatively good living conditions.
The other type of population was from the community
group, usually people sharing the same air for a full work-
ing day. In our study, we found a reverse correlation be-
tween the size of the room and the positivity of the IGRAs,
but associated this correlation with a higher degree of
exposure.
Although data about ventilation was not collected in
this study, it suggests that in relation to environmental
risk factors, more than the number of people in contact
with the TB case in a limited environment, it is the ventila-
tion of the room that is the main determinant in the trans-
mission of infection in addition to the time of exposure. A
study carried out in Peru found that opening windows and
doors provided more than double the amount of ventilation
of the mechanical ones and the risk of TB infection was
lower [28].
The main limitation of our study was the small num-
ber of patients included, given the difficulty of enrolling
patients with smear-positive pulmonary TB in our envir-
onment. However, the results are sufficiently consistent
to show the strong association between the IGRAs and
the risk factors involved in the LTBI.
Conclusions
In conclusion, comparing the performance of the TST
and IGRA tests in contacts with smear positive pulmon-
ary TB, we found that both IGRAs were associated with
certain host-related risk factors involved in the transmis-
sion of disease, such as the presence of cough. On the
other hand, the study suggests that some environmental
risk factors, such as the lack of ventilation associated
with the time of exposure, may be crucial for the transmis-
sion, aside from the status smear of the index case and the
diagnostic delay. A larger study would be needed, in order
to confirm all the findings and better characterize the true
role of the different variables involved in the transmission
of the disease.
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